JAK2V617F allele burden is associated with transformation to myelofibrosis

Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

(2010) O. Abdel-Wahab et al.   CANCER RESEARCH

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications

(2010) F Passamonti et al.   LEUKEMIA

JAK2V617F allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy

(2010) Richard T. Silver et al.   LEUKEMIA RESEARCH

Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients

(2009) Alberto Alvarez-Larrán et al.   BRITISH JOURNAL OF HAEMATOLOGY

The presence ofJAK2V617F in primary myelofibrosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea

(2008) Shireen Sirhan et al.   AMERICAN JOURNAL OF HEMATOLOGY

Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens

(2008) Alison R. Moliterno et al.   EXPERIMENTAL HEMATOLOGY

Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

(2008) O Benjamini et al.   LEUKEMIA

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD)

(2007) Maya Koren-Michowitz et al.   LEUKEMIA RESEARCH